Abbott (ABT) Tops Q4 EPS by 13c; Offers Guidance
Tweet
Share
E-mail
Get Alerts ABT Hot Sheet
Price: $102.61 +0.37%
Revenue Growth %: +14.2%
Financial Fact:
Research and development: 352M
Today's EPS Names:
VIVO, OCCI, ALZN, More
Revenue Growth %: +14.2%
Financial Fact:
Research and development: 352M
Today's EPS Names:
VIVO, OCCI, ALZN, More
Join SI Premium – FREE
Abbott (NYSE: ABT) reported Q4 EPS of $1.32, $0.13 better than the analyst estimate of $1.19. Revenue for the quarter came in at $11.5 billion versus the consensus estimate of $10.58 billion.
GUIDANCE:
Abbott sees FY2022 EPS of $4.70, versus the consensus of $4.78.
For earnings history and earnings-related data on Abbott (ABT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Westinghouse said to seek over $50 billion valuation in planned IPO
- Kestra Medical Technologies, Ltd. (KMTS) Reports Q1 Loss of $0.75/sh
- Forgent Power Solutions, Inc. (FPS) Tops Q2 EPS by 1c, Beats on Revenue; Offers FY27 Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
